CELC PRESS-RELEASE SEC Filing Analysis

Latest settled — T+20d

CELC ▼ -31.95% at T+20d

NEUTRAL call ✗ call lost -31.95% · α vs SPY -35.08% · entry $130.71 → $88.95

Next anchor: T+60d in 7w

Last close $88.55 (close Jun 12) · -32.25% from $130.71 entry

Entry anchored
May 7, 04:49 AM ET
via Databento tick

T+1d

+0.27%

call +0.27% · α -0.56%

$131.06

settled 5w ago

T+5d

-4.77%

call -4.77% · α -6.28%

$124.47

settled 5w ago

T+20d

-31.95%

call -31.95% · α -35.08%

$88.95

settled 10d ago

T+60d

—

call — · α —

—

in 7w

Price Chart

Loading chart...

Executive Summary

Celcuity announced it will release Q1 2026 financial results on May 14, 2026, after market close. The press release contains no financial data for the current period; it only provides logistics for the earnings call. The most recent reported quarter (Q4 2025) showed an EPS miss of -9.0% versus consensus, but the stock has rallied significantly on prior neutral filings, suggesting strong investor sentiment tied to clinical pipeline progress.

Actionable Insight

This is a routine earnings date announcement with no new financial information. The stock's recent strong rally on clinical momentum (VIKTORIA-1/2 trials) suggests the May 14 earnings call will be closely watched for pipeline updates and cash runway. Monitor for any pre-announcement or data readout before the call.

Key Facts

Q1 2026 earnings release scheduled for May 14, 2026 after market close
Conference call at 4:30 PM ET on same day
No financial results or guidance provided in this press release
Prior quarter (Q4 2025) EPS of -$0.97 missed consensus of -$0.89 by 9.0%
Stock has rallied +28.65% over 20 days following the prior neutral filing
Market cap is $6.7B with 89% analyst buy rating

Financial Impact

No financial data in this filing; prior quarter EPS miss of 9%

Risk Factors

No financial data in this filing — all materiality deferred to May 14 release
Prior quarter EPS miss of 9% may indicate continued cash burn without revenue
Stock at $6.7B market cap with no approved products — binary clinical risk

Market Snapshot

Exchange

Nasdaq

Sector

Services-Medical Laboratories

Analyst Consensus

89% bullish (18 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

Document	Accession Number
PRESS-RELEASE Data (Synthetic)	press-3289927

12 reports for CELC

T+1T+5T+20T+60

20% Hit rate 1 of 5 directional calls best @ T+5▲ +0.40%May 14, 2026

Filters

Reports for CELC — sortable, filterable
	Type				Now
Jun 11, 2026 3d ago	Institutional Cluster BULLISH ★ 5/10	$89.78 awaiting T+1	awaiting T+1	—	$88.55 (−1.37%)
Jun 8, 2026 6d ago	8-K MIXED ★ 6/10	$87.39 awaiting T+1	awaiting T+1	—	$88.55 (+1.33%)
Jun 5, 2026 9d ago	424B5 MIXED ★ 6/10	$92.47 awaiting T+1	awaiting T+1	—	$88.55 (−4.24%)
Jun 4, 2026 11d ago	Press Release MIXED ★ 6/10	$92.47 $88.28	▼ −4.53%	▼ −1.93%	$88.55 (−4.24%)
Jun 3, 2026 11d ago	Press Release BEARISH ★ 6/10	$88.95 $92.47	▼ −3.96%	▼ −3.56%	$88.55 (+0.45%)
Jun 3, 2026 11d ago	424B5 BEARISH ★ 6/10	$88.95 $92.47	▼ −3.96%	▼ −3.56%	$88.55 (+0.45%)
Jun 2, 2026 12d ago	8-K BULLISH ★ 8/10	$91.42 $88.95	▼ −2.70%	▼ −2.01%	$88.55 (−3.14%)
May 14, 2026 4w ago	Press Release BULLISH ★ 7/10	$137.68 $132.18	▼ −3.99%	▼ −3.93%	$88.55 (−35.68%)
May 7, 2026 5w ago	Press Release NEUTRAL ★ 3/10	$130.71 $131.06	▲ +0.27%	▼ −0.56%	$88.55 (−32.25%)
May 4, 2026 5w ago	144 NEUTRAL ★ 2/10	$144.98 $141.69	▼ −2.27%	▼ −3.06%	$88.55 (−38.92%)

US Market Status

Market Closed — Opens in 5h 12m

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access